Showing results (1561-1570 of 2,081) with videos related to
Sort By:
Pageof 209
American Journal of Hematology|June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patientsStephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.Nature|March 2, 2010
Systems survey of endocytosis by multiparametric image analysisClaudio Collinet, Martin Stöter, Charles R Bradshaw, et al.Journal of Surgical Oncology|April 19, 2017
Identifying a subset of patients with DCIS who have a low likelihood of residual disease at surgical excision following a core needle biopsyBrittany L Murphy, Alexandra B Gonzalez, Amy L Conners, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic ExperienceArushi Khurana, Ivana N Micallef, Betsy R LaPlant, et al.Annals of Surgery|March 27, 2025
Greater Familiarity Between Surgeon and Operating Room Allied Health Staff is Associated with Shorter Case Duration - A Multi-Institutional StudyDavid A Etzioni, Melana Elliot, Lani MacMillan, et al.International Journal of Surgery (London, England)|March 3, 2018
Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)John R Bergquist, Harsh N Shah, Elizabeth B Habermann, et al.Blood|January 5, 2002
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphomaStephen M Ansell, Thomas E Witzig, Paul J Kurtin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemiaJames R Cerhan, Celine M Vachon, Thomas M Habermann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphomaThomas M Habermann, Edie A Weller, Vicki A Morrison, et al.Molecular and Clinical Oncology|November 29, 2017
Claudin-1 expression in cervical cancerFriederike Hoellen, Annika Waldmann, Constanze Banz-Jansen, et al.Pageof 209